Triple-Negative Breast Cancer
Breakthrough Antibody Targeting SFRP2 Protein Halts Aggressive Breast Cancer in Preclinical Models
Researchers at MUSC Hollings Cancer Center have developed a humanized antibody that neutralizes a key protein driving tumor growth and metastasis in triple-negative breast cancer.
